ICH guidelines--implementation of the 3Rs (refinement, reduction, and replacement): incorporating best scientific practices into the regulatory process.
An overview of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) is described. ICH was established through cooperation of the regulatory agencies and industrial parties of three main regions involved in pharmaceuticals: the European Union, the United States, and Japan. The purpose of the ICH is to make recommendations to achieve greater harmonization regarding interpretation and application of technical guidelines and requirements for product registration in an effort to reduce or obviate the need to duplicate the testing carried out during the research and development of new medicines. The main purpose of ICH was not to foster the 3Rs per se; however, harmonization of guidelines has eliminated duplications of similar tests to satisfy the specific requirements of each region. The ICH process has contributed to mutual understanding of the regulatory requirements and has decreased the number of unnecessary animal experiments. Specific examples of the contributions of ICH harmonization to the 3Rs are described.
Ohno
Yasuo
Y
Division of Pharmacology, Biological Safety Research Center, National Institute of Health Services, Tokyo, Japan.
D000826:Animal Testing Alternatives / Q000331:legislation & jurisprudence*; D000818:Animals; D000830:Animals, Laboratory; D033161:Government Regulation; D017408:Guidelines as Topic; D006801:Humans; D007391:International Cooperation; D004364:Pharmaceutical Preparations; D018675:Toxicity Tests / Q000379:methods*
D004364:Pharmaceutical Preparations